FBTvsGNMXETF Comparison
VS
First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) belongs to the US Health Care segment. Corgi Genomics & Precision Medicine ETF (GNMX) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Healthcare. FBT is more expensive with a Total Expense Ratio (TER) of 0.54%, versus 0.35% for GNMX. Run a side-by-side ETF comparison of FBT and GNMX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FBT vs GNMX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/29/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FBT GNMX | +1.05%-2.44% | +24.74%+18.01% | +21.59%n/a | +50.68%n/a | +62.12%n/a | +49.66%n/a |
| Flows | FBT GNMX | -$147M- | -$95M+$1M | +$976M- | +$1.03B- | +$584M- | +$244M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FBT GNMX | +21.62%+27.51% | +21.24%n/a | +20.64%n/a | +22.13%n/a |
| Max drawdown | FBT GNMX | -4.37%-8.53% | -14.27%n/a | -19.92%n/a | -29.91%n/a |
| Max drawdown duration | FBT GNMX | 22d24d | 126dn/a | 237dn/a | 1159dn/a |
Trading data
FBT | GNMX | |
Last sale 7/30/2026 at 1:30 PM | $252.66 | |
| Previous close 07/30/2026 | $250.47 | |
| Consolidated volume 07/30/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GNMX
is actively managed and doesn’t replicate an indexFBT | GNMX | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/30/2026 at 1:30 PM
Live
Closed
FBT | GNMX | |
|---|---|---|
| Last price | $252.66 | – |
| 1D performance | +0.87% | – |
| AuM | $2.74 B | $1.67 M |
| E/R | 0.54% | 0.35% |
Characteristics
FBT | GNMX | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | First Trust | Corgi Funds |
| Benchmark | NYSE Arca Biotechnology Index | - |
| N° of holdings | 30 | 57 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 19, 2006 | May 6, 2026 |
| ESG | No | No |
Advertisement
Exposure
Countries
FBT
USA
84.94%
Other
15.06%
GNMX
USA
89.37%
Other
10.63%
Sectors
FBT
Healthcare
99.93%
Other
0.07%
GNMX
Healthcare
98.21%
Other
1.79%
Advertisement
Diversification
FBT
Total weight of top 15 holdings out of 15
59.85%
GNMX
Total weight of top 15 holdings out of 15
53.1%
Top 15 holdings
Data as of June 30, 2026
FBT
Corcept Therapeutics, Inc.
5.66%
NeoGenomics, Inc.
5.22%
Veracyte, Inc.
5.16%
Bruker Corp.
4.33%
Alkermes Plc
4.16%
Illumina, Inc.
4.08%
Krystal Biotech, Inc.
3.85%
Natera, Inc.
3.84%
Axsome Therapeutics, Inc.
3.62%
Neurocrine Biosciences, Inc.
3.49%
Bio-Techne Corp.
3.43%
Arrowhead Pharmaceuticals, Inc.
3.31%
Exelixis, Inc.
3.27%
Biogen, Inc.
3.25%
Incyte Corp.
3.18%
GNMX
Thermo Fisher Scientific, Inc.
7.80%
Vertex Pharmaceuticals, Inc.
6.73%
Guardant Health, Inc.
3.85%
Illumina, Inc.
3.84%
Revolution Medicines, Inc.
3.83%
Alnylam Pharmaceuticals, Inc.
3.77%
Moderna, Inc.
3.71%
Incyte Corp.
3.09%
Genmab A/S
2.54%
Bio-Techne Corp.
2.50%
Ionis Pharmaceuticals, Inc.
2.49%
Krystal Biotech, Inc.
2.43%
BioMarin Pharmaceutical, Inc.
2.33%
Arrowhead Pharmaceuticals, Inc.
2.12%
uniQure NV
2.07%
Frequently asked questions about FBT and GNMX
Which ETF is bigger: FBT or GNMX?
As of July 29, 2026, FBT holds $2.74 B in assets under management (AUM), while GNMX manages $1.67 M.
What sectors do the FBT and GNMX ETFs invest in?
FBT leans toward sectors like Healthcare. Meanwhile, GNMX focuses on Healthcare.
What are the top holdings of the FBT ETF and GNMX ETF?
FBT top holdings include Corcept Therapeutics, Inc., NeoGenomics, Inc. and Veracyte, Inc.. GNMX holds in its top three: Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals, Inc. and Guardant Health, Inc..
Which ETF is more diversified: FBT or GNMX?
FBT holds 30 securities with 59.85% of its assets in the top 15. GNMX has 57 securities and a top 15 weight of 53.1%.
Advertisement
Latest news about FBT & GNMX
Advertisement
